Sofinnova Investments’s Calithera Biosciences, Inc CALA Stock Holding History

Sofinnova Investments’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-37,877	Closed	-$1.83M	–	79
2021 Q1	$1.83M	Buy	37,877 +12,861	+51%	+$749K	0.11%	63
2020 Q4	$2.46M	Buy	25,016 +351	+1%	+$30.8K	0.15%	58
2020 Q3	$1.7M	Sell	24,665 -27,355	-53%	-$2.39M	0.13%	62
2020 Q2	$5.49M	Buy	52,020 +11,070	+27%	+$1.31M	0.35%	55
2020 Q1	$3.64M	Sell	40,950 -31,991	-44%	-$3.81M	0.34%	40
2019 Q4	$8.33M	Buy	72,941 +24,698	+51%	+$1.86M	0.6%	32
2019 Q3	$2.98M	Buy	48,243 +21,751	+82%	+$1.74M	0.27%	52
2019 Q2	$2.07M	Buy	+26,492	New	+$3.01M	0.19%	57
2018 Q3	–	Sell	-14,861	Closed	-$1.49M	–	69
2018 Q2	$1.49M	Buy	14,861 +13,865	+1,392%	+$1.57M	0.17%	52
2018 Q1	$126K	Buy	+996	New	+$155K	0.02%	52

Other funds holding CALA

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DMPV

Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sofinnova Investments's CALA Position: Q2 2021 in Review

Sofinnova Investments sold out of Calithera Biosciences, Inc (CALA) in Q2 2021, closing a stake of 37,877 shares — an estimated $1.83M sold.

Sofinnova Investments first reported a position in CALA in Q1 2018 and held it in 10 quarters. The position peaked at $8.33M in Q4 2019. 76 funds tracked by Wall St. Rank hold CALA as of Q2 2021.

Sofinnova Investments reported no remaining Calithera Biosciences, Inc position as of Q2 2021 after selling out during the quarter.
Sofinnova Investments sold 37,877 Calithera Biosciences, Inc shares in Q2 2021, an estimated $1.83M.
Sofinnova Investments first reported a position in Calithera Biosciences, Inc in Q1 2018 and held it in 10 quarters.
Sofinnova Investments's Calithera Biosciences, Inc position peaked at $8.33M in Q4 2019.
76 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2021.

Based on Sofinnova Investments's 13F filing for Q2 2021, filed 16 Aug 2021.